SEC Form 424B5 filed by Guardian Pharmacy Services Inc.
$GRDN
Retail-Drug Stores and Proprietary Stores
Consumer Staples
Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/10/2025 | $30.00 | Outperform | Oppenheimer |
| 10/21/2024 | $21.00 | Outperform | Raymond James |
| 10/21/2024 | $22.00 | Buy | Truist |
Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN) today announced the launch of a proposed underwritten public offering (the "Offering") of 5,000,000 shares of its Class A common stock, consisting of 3,980,000 shares being offered by certain selling stockholders and 1,020,000 newly issued shares being offered by Guardian as part of a non-dilutive "synthetic secondary" transaction, as described below. In addition, the selling stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 750,000 shares of Class A common stock at the public offering price, less the underwriting discount. The proposed Offering is considered non-dilutive as Guardian inte
Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the fourth quarter and full year ended December 31, 2025. The Company also raised its full-year 2026 Adjusted EBITDA guidance. Fourth Quarter Financial Results Revenue of $397.6 million, up 17% year-over-year with organic growth of 12%. Residents served ended the quarter at approximately 205,000, up 10% year-over-year. Net Income of $21.3 million, up 81% from $11.8 million in the prior-year period. Adjusted EBITDA of $39.5 million, up 53% year over year. Diluted EPS of $0.33 for the quarter, with Adjusted
Guardian Pharmacy Services, Inc. (NYSE:GRDN) today announced that the company will participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference. Fred Burke, President and Chief Executive Officer, and David Morris, Chief Financial Officer, will participate in a fireside chat on Monday, March 16, 2026, at 10:40 a.m. Eastern Time. A live audio webcast of the session will be available at https://investors.guardianpharmacy.com. A replay will be accessible shortly after the event and will remain available for 90 days. About Guardian Pharmacy Services Guardian Pharmacy Services is one of the nation's leading long-term care pharmacy services companies. Through its local
Oppenheimer initiated coverage of Guardian Pharmacy Services with a rating of Outperform and set a new price target of $30.00
Raymond James initiated coverage of Guardian Pharmacy Services with a rating of Outperform and set a new price target of $21.00
Truist initiated coverage of Guardian Pharmacy Services with a rating of Buy and set a new price target of $22.00
4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
424B5 - Guardian Pharmacy Services, Inc. (0001802255) (Filer)
10-K - Guardian Pharmacy Services, Inc. (0001802255) (Filer)
8-K - Guardian Pharmacy Services, Inc. (0001802255) (Filer)
4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the fourth quarter and full year ended December 31, 2025. The Company also raised its full-year 2026 Adjusted EBITDA guidance. Fourth Quarter Financial Results Revenue of $397.6 million, up 17% year-over-year with organic growth of 12%. Residents served ended the quarter at approximately 205,000, up 10% year-over-year. Net Income of $21.3 million, up 81% from $11.8 million in the prior-year period. Adjusted EBITDA of $39.5 million, up 53% year over year. Diluted EPS of $0.33 for the quarter, with Adjusted
Guardian Pharmacy Services, Inc. (NYSE:GRDN) today announced that it will release fourth quarter and full-year 2025 financial results after market close on Wednesday, March 11, 2026. Management will host a conference call to discuss the results at 4:30 p.m. Eastern Time. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing +1 (646) 564-2877 for U.S. participants, or +1 (800) 549-8228 for international participants, and referencing conference ID "93533." A replay will be available shortly after the call's completion and will remain available for approximately 60 days. About Guardian
Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the third quarter ended September 30, 2025. The Company also raised its full-year revenue and Adjusted EBITDA guidance. Third Quarter Financial Results Revenue of $377.4 million, up 20% year-over-year. Residents served ended the quarter at approximately 204,000, up 13% year-over-year. Net Income (loss) of $9.6 million, compared to ($105.8) million in the prior-year period. Such year-over-year comparison is not meaningful due to income tax expense1 in the recently completed quarter, and certain one-time share-based
Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies is pleased to announce the appointment of Ashley Stockton as Senior Director, Head of Investor Relations. She will be responsible for leading the investor relations strategy and serving as the primary liaison with shareholders, analysts, and the broader investment community. Ashley joins Guardian with nearly thirty years of experience in equity markets. Most recently, she served as Head of Southeast Institutional Equity Sales for J.P. Morgan, where she built and managed strategic partnerships with institutional investors, delivering dif
Guardian Pharmacy Services, (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies, today announced that Freedom Pharmacy, an independent LTC pharmacy based in Randolph, New Jersey, is joining the Guardian family. The pharmacy will continue to operate under the name Freedom Pharmacy and serve residents in assisted living and skilled nursing, as well as individuals with intellectual and developmental disabilities throughout North, Northwest and Central New Jersey, with plans to further increase its presence across the Garden State in the future. This strategic partnership expands Guardian's Mid-Atlantic footprint and marks its first vent
SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)
SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)
SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)